FUNDACION PARA LA INVESTIGACION E INNOVACION BIOSANITARIA DE ATENCION PRIMARIA

Their core work

FIIBAP is a Madrid-based biomedical research foundation focused on primary healthcare innovation. They serve as a clinical validation and real-world testing partner, bringing primary care expertise — patient populations, clinical environments, and healthcare delivery knowledge — into European research consortia. Their work spans two distinct domains: improving patient care through digital health tools and affective computing, and providing medical expertise to security and first-responder technology projects. In practice, they act as the bridge between technology developers and the primary care system where solutions are ultimately deployed.

What they specialise in

How they've shifted over time

FIIBAP began with clinical research in rare diseases (Sjogren syndrome cohort studies, big data analytics for clinical trials) and early involvement in crisis management technology. From 2020 onward, their focus shifted decisively toward first-responder technologies — mixed-reality training, smart wearables, triage systems, and operations in adverse conditions — while maintaining a parallel track in person-centred care and behavioural health. The security-health crossover intensified, suggesting they carved out a niche as the primary-care medical authority within emergency response consortia.

FIIBAP is consolidating as a go-to primary care partner for security and emergency response projects, likely offering clinical trial sites, patient validation, and medical domain expertise to technology-heavy consortia.

How they like to work

FIIBAP operates almost exclusively as a third party (10 of 11 projects), meaning they provide specialized services or access — likely clinical sites, patient cohorts, or medical validation — without taking on major project management responsibilities. Despite this behind-the-scenes role, they have connected with 191 unique partners across 28 countries, indicating they are a trusted and frequently recruited contributor. This is a low-overhead, high-reliability partner: they deliver specific expertise without competing for leadership.

Despite their third-party role, FIIBAP has built an extensive network of 191 unique consortium partners across 28 countries, reflecting broad European reach. Their connections span both the health research community and the security/defence technology ecosystem.

What sets them apart

FIIBAP occupies a rare niche at the intersection of primary healthcare and security technology. While most primary care research foundations stay within health, FIIBAP has become a recurring medical partner in first-responder and crisis management projects — providing the clinical reality check that technology-driven security consortia need. For consortium builders, they offer something hard to find: a credible healthcare institution comfortable operating in the security domain, with proven ability to provide clinical validation across both sectors.

Highlights from their portfolio

• HarmonicSS
  Their only project as a direct participant with EC funding (€93,750), focused on harmonizing Sjogren syndrome cohorts across Europe — represents their clinical research roots.
• MED1stMR
  Mixed-reality training for medical first responders with haptic feedback — exemplifies their unique health-security crossover positioning.
• CANCERLESS
  Cancer prevention among homeless populations — an unusual and socially impactful topic combining primary care access with vulnerable population outreach.